TABLE 2 

P-gp–overexpressing cell IC50 values, tβ-statistic values for inhibitors, and IC50 slope factor β

CellaLaboratoryaInhibitorIC50btβcLaboratory Average <tβ>dβe
MDCK2Carvedilol6.811.51.0
2Diltiazem53.97.40.7
2Isradipine35.47.01.0
2Mibefradil7.311.01.0
2Nicardipine2.67.71.0
2Quinidine8.49.01.6
2Ranolazine68.210.71.3
2Verapamil11.814.99.81.2
7Carvedilol8.111.21.5
7Nicardipine5.514.51.1
7Ranolazine114.05.31.8
7Verapamil32.219.712.71.1
Caco-26Carvedilol0.710.70.9
6Diltiazem8.317.31.2
6Isradipine7.214.80.9
6Nicardipine1.06.81.1
6Quinidine2.314.81.0
6Ranolazine9.810.71.0
6Verapamil1.813.012.61.0
11Carvedilol1.47.01.1
11Diltiazem5.710.50.9
11Isradipine2.68.60.6
11Nicardipine1.88.51.4
11Quinidine2.37.50.9
11Ranolazine15.315.39.61.6
LLC-PK2Mibefradil4.58.51.2
2Quinidine15.76.91.2
2Ranolazine55.45.71.2
2Verapamil8.66.16.81.0
  • a Cell and laboratory number as indicated in Bentz et al. (2013).

  • b IC50 values are taken from Bentz et al. (2013).

  • c tβ was calculated as described by O’Connor et al. (2015) and replaces tαβ used by Bentz et al. (2013). This data quality statistic measures the goodness of fit of the experimental IC50 data to a logistic curve, the canonical shape of an IC50 curve. The present work required that tβ > 5 for all data analyzed, a lower limit defined from preliminary analysis.

  • d <tβ>, the laboratory average for tβ, was calculated for the qualified inhibitors.

  • e β is the slope factor for the logistic IC50 curve, also known as the Hill equation (Hill, 1913), calculated from the fit to the logistic equation (O’Connor et al., 2015). It is used in all commercial software fitting programs for IC50 plots as the slope factor estimate of the IC50 curve as it passes through the estimated IC50. Any other interpretations of its meaning, e.g., binding cooperativity, are inapplicable to P-gp as analyzed in these data fits (see Discussion).